Literature DB >> 23133458

Prevention of substance use in children/adolescents with mental disorders: a systematic review.

Nadia Salvo1, Kathryn Bennett, Amy Cheung, Yvonne Chen, Maureen Rice, Brian Rush, Heather Bullock, Anne Bowlby.   

Abstract

OBJECTIVE: WE CONDUCTED A SYSTEMATIC REVIEW TO ANSWER THE QUESTION: Among youth ≤18 years of age with a mental disorder, does substance use prevention compared to no prevention result in reduced rates of substance use/abuse/disorder (SUD)? The review was requested by the Ontario Ministry of Health and Long-term Care through the Canadian Institutes for Health Research Evidence on Tap program.
METHODS: A four-step search process was used: Search 1 and 2: Randomized controlled trials (RCTs) that evaluated a SUD prevention intervention in individuals with a mental disorder who were: 1) ≤18 years; or, 2) any age. Search 3: Observational studies of an intervention to prevent SUD in those with mental disorder. Search 4: RCTs that evaluated a SUD primary prevention skills-based intervention in high-risk youth ≤18 years.
RESULTS: Searches 1 and 2: one RCT conducted in youth was found; Search 3: two observational studies were found. All three studies reported statistically significant reductions in substance use. Search 4: five RCTs were found with mixed results. Methodological weaknesses including inadequate study power may explain the results.
CONCLUSIONS: Little is known about effective interventions to prevent SUD in youth with a mental disorder. Effective SUD primary prevention programs exist and should be evaluated in this high-risk group.

Entities:  

Keywords:  Mental health disorder; concurrent disorder; prevention; substance use disorder; systematic review

Year:  2012        PMID: 23133458      PMCID: PMC3490525     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN: 1719-8429


  21 in total

1.  Promoting intervention fidelity. Conceptual issues, methods, and preliminary results from the EARLY ALLIANCE prevention trial.

Authors:  J E Dumas; A M Lynch; J E Laughlin; E Phillips Smith; R J Prinz
Journal:  Am J Prev Med       Date:  2001-01       Impact factor: 5.043

2.  Effectiveness of a universal drug abuse prevention approach for youth at high risk for substance use initiation.

Authors:  Kenneth W Griffin; Gilbert J Botvin; Tracy R Nichols; Margaret M Doyle
Journal:  Prev Med       Date:  2003-01       Impact factor: 4.018

3.  A new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of health behavior research.

Authors:  Belinda Borrelli; Deborah Sepinwall; Denise Ernst; Albert J Bellg; Susan Czajkowski; Rosemary Breger; Carol DeFrancesco; Chantal Levesque; Daryl L Sharp; Gbenga Ogedegbe; Barbara Resnick; Denise Orwig
Journal:  J Consult Clin Psychol       Date:  2005-10

4.  Social skills training for drug prevention in high-risk female adolescents.

Authors:  L A Palinkas; C J Atkins; C Miller; D Ferreira
Journal:  Prev Med       Date:  1996 Nov-Dec       Impact factor: 4.018

Review 5.  Interpreting treatment effects in randomised trials.

Authors:  G H Guyatt; E F Juniper; S D Walter; L E Griffith; R S Goldstein
Journal:  BMJ       Date:  1998-02-28

Review 6.  Comorbid psychopathology in adolescents and young adults treated for substance use disorders: a review.

Authors:  Christianne Couwenbergh; Wim van den Brink; Kirsten Zwart; Coby Vreugdenhil; Patricia van Wijngaarden-Cremers; Rutger J van der Gaag
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-09       Impact factor: 4.785

7.  Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

Authors:  J Biederman; T Wilens; E Mick; T Spencer; S V Faraone
Journal:  Pediatrics       Date:  1999-08       Impact factor: 7.124

8.  Prevalence and development of psychiatric disorders in childhood and adolescence.

Authors:  E Jane Costello; Sarah Mustillo; Alaattin Erkanli; Gordon Keeler; Adrian Angold
Journal:  Arch Gen Psychiatry       Date:  2003-08

9.  Child psychiatric epidemiology and Canadian public policy-making: the state of the science and the art of the possible.

Authors:  Charlotte Waddell; David R Offord; Cody A Shepherd; Josephine M Hua; Kimberley McEwan
Journal:  Can J Psychiatry       Date:  2002-11       Impact factor: 4.356

10.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18
View more
  5 in total

1.  Early-life risperidone enhances locomotor responses to amphetamine during adulthood.

Authors:  Bobbie Lee Stubbeman; Clifford J Brown; Justin R Yates; Mark E Bardgett
Journal:  Eur J Pharmacol       Date:  2017-07-14       Impact factor: 4.432

2.  Substance-use in Childhood and Adolescence: A Brief Overview of Developmental Processes and their Clinical Implications.

Authors:  Natalie Castellanos-Ryan; Maeve O'Leary-Barrett; Patricia J Conrod
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-02

3.  A Prospective Study on the Influence of Scholastic Factors on the Prevalence and Initiation of Illicit Drug Misuse in Adolescence.

Authors:  Zoran Zubak; Natasa Zenic; Ljerka Ostojic; Ivana Zubak; Haris Pojskic
Journal:  Int J Environ Res Public Health       Date:  2018-04-27       Impact factor: 3.390

Review 4.  School-based interventions for preventing substance use in indigenous children ages 7-13: a scoping review protocol.

Authors:  Geoffrey Maina; Taryn Phaneuf; Megan Kennedy; Maeve Mclean; Ann Gakumo; Joseph Nguemo; Alexandra King; Solomon Kasha Mcharo
Journal:  BMJ Open       Date:  2020-02-12       Impact factor: 2.692

5.  Principles of Care for Young Adults With Co-Occurring Psychiatric and Substance Use Disorders.

Authors:  Andrea E Spencer; Sarah E Valentine; Jennifer Sikov; Amy M Yule; Heather Hsu; Eliza Hallett; Ziming Xuan; Michael Silverstein; Lisa Fortuna
Journal:  Pediatrics       Date:  2021-01       Impact factor: 7.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.